Eukaryotic translation elongation factor 1 alpha 1 pseudogene 26 (EEF1A1P26)

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 26 (EEF1A1P26) is one of over 40 pseudogenes derived from the parent EEF1A1 gene, which encodes a translation elongation factor central to protein biosynthesis[1][3]. EEF1A1P26 does **not encode a functional protein** and is currently classified as a pseudogene—evolutionarily related to EEF1A1 but lacking coding potential due to accumulated mutations and disruptive genomic structure[1][3]. There is no evidence that EEF1A1P26 is expressed at the RNA level, nor that it participates directly in biological pathways, disease processes, or drug interactions. Currently, its main relevance is as a genomic locus reflecting the evolutionary complexity of the EEF1A1 gene family. **Notes:** - EEF1A1, the parental gene, encodes a cytosolic translation elongation factor but EEF1A1P26 itself is a processed pseudogene, with no documented protein product, enzyme activity, or receptor function[1][3]. - Large families of EEF1A1 pseudogenes are common, but only a handful have been linked as potential non-coding RNA regulators or have disease associations; EEF1A1P26 does not appear in such reports[3]. - There are currently no known drugs, biomarker roles, or therapeutic safety considerations connected to EEF1A1P26, and it should **not** be considered a therapeutic target in the classical sense[1][3].

Other names

EEF1A1P26